Skip to main content

Non-Small Cell Lung Cancer Clinical Trials

Review the non-small cell lung cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 501-525 of 537

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Status: Active
Location: 198 locations
Using Urine Samples to Identify Lung Cancer
Status: Active
Location: 7 locations
Response of Bone Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers with Actionable Driver Mutations
Status: Active
Location: 2 locations
Biomarker Analysis in Tumor and Blood Samples from Patients with Stage IV Non-small Cell Lung Cancer and EGFR, ALK, ROS1, or BRAF Mutations Undergoing Targeted Therapy
Status: Active
Location: UCHealth University of Colorado Hospital, Aurora, Colorado
A Pilot Study to Assess the Diversity of Gut Microbiome in Metastatic Non-Small Cell Lung Cancer (NSCLC) in Correlation to Treatment Effects and Adverse Effects
Status: Active
Location: UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California
The Effect of Pembrolizumab on Quality of Life in Patients with Treatment-Naive Locally Advanced or Metastatic Non-small Cell Lung Cancer with Poor Performance Status
Status: Active
Location: 4 locations
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-04)
Status: Active
Location: 3 locations
National Cancer Institute “Cancer Moonshot Biobank”
Status: Active
Location: 147 locations
Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Status: Active
Location: 12 locations
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Status: Active
Location: 11 locations
GEMINI-NSCLC: NSCLC Biomarker Study
Status: Active
Location: 8 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Status: Active
Location: 7 locations
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Status: Active
Location: 7 locations
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
Status: Active
Location: 9 locations
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Status: Active
Location: 4 locations
Comparison of Surgery to Stereotactic Body Radiation Therapy (SBRT) in Patients With Stage I Non-Small Cell Lung Cancer
Status: Active
Location: 3 locations
Qualitative Study on Detection and Treatment of Non-small Cell Lung Cancer in Patients with a History of Alcohol or Substance Use Disorder
Status: Active
Location: 2 locations
Cancer-Related Fatigue During Maintenance Immunotherapy for Non-Small Cell Lung Cancer
Status: Active
Location: 2 locations
A Multi-dimensional Atlas of Lung Premalignancy, the Lung Pre-Cancer Atlas (PCA) Project Study
Status: Active
Location: 2 locations
Registry Trial and Needs Assessment of Patients with Young-Onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Predictive Biomarkers for Pneumonitis after Chemoradiotherapy and Immunotherapy in Patients with Non-small Cell Lung Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Evaluation of Exosomes Isolation from Bronchial Washings in Patients with Non-Small Cell Lung Cancer Undergoing Surgical Resection
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Status: Active
Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois
Insomnia in Patients with Metastatic Lung Cancer
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota